About the Biotech Showcase™ 2025 program

Discover key strategies to secure the funding and partnerships necessary for growth in today’s competitive biotech landscape. Learn from experts who have successfully navigated the complexities of early-stage biotech commercialization.

Hear from top pharmaceutical leaders about the evolving role of Big Pharma in innovation, partnerships, and investment across the biotech ecosystem. Gain valuable insights into how they are driving the next wave of breakthroughs.

Explore the rapidly growing biotech markets in the Asia Pacific region and the unique opportunities and challenges companies face in this region. Understand the trends shaping the future of healthcare in Asia and how global collaborations are influencing the region's growth.

Join us for an in-depth conversation about the importance of healthcare access and equity. This panel will examine how biotech can play a critical role in improving health outcomes across underserved populations worldwide.

Learn from seasoned investors and entrepreneurs about the nuances of securing early-stage funding. This session will cover what it takes to attract seed capital and how to navigate early investor relationships to set your company up for long-term success.

Explore the current state of biotech funding, from venture capital to public markets, and understand what it takes to thrive in today’s financial landscape. This panel will address trends in investment and how companies can adapt to evolving market dynamics.

Discover how biotech is revolutionizing women’s health. This session will highlight new innovations and investment opportunities in this critical area of healthcare.

Gain insights into the latest headlines, trends, and conversations happening around the biotech industry. This interactive session will keep you updated on the most important developments from around the Square.

Techbio is rapidly transforming the biotech industry with advancements in AI, genomics, and bioengineering. This panel will delve into the most promising investment areas, how to separate hype from reality, and how to mitigate risks while maximizing returns in a fast-moving landscape

AI and machine learning are reshaping healthcare, driving innovation, and improving patient care. This session explores how AI can deliver more personalized, real-time patient experiences while reducing costs and improving outcomes.

The convergence of AI and biology is revolutionizing drug development, enabling faster and more accurate discoveries. This panel will discuss how AI is accelerating drug timelines, reducing costs, and leveraging experimental data for better outcomes.

Tech giants are entering the biotech space, redefining innovation, investment, and compliance. This session will explore how these companies are driving advancements in biotech R&D, collaborating with biotech firms, and navigating regulatory landscapes.